Market Overview
The medical device verification and validation market provides the critical quality assurance and testing infrastructure that ensures medical devices meet established safety and performance standards prior to commercial release. According to publicly available research, the market was valued at approximately $42.1 billion in 2021 and is projected to grow to roughly $106.2 billion by 2030, reflecting sustained expansion at a CAGR of 11.2%. This growth trajectory is underpinned by tens of billions of dollars in annual testing expenditures across the global medical device industry, covering everything from software validation to hardware safety assessments.
- •Market size estimated at approximately $61.2 billion in 2025, up from $42.1 billion in 2021
- •Projected to reach roughly $106.2 billion globally by 2030 at a CAGR of 11.2%
- •Covers testing, certification, quality assurance, and regulatory compliance services for medical devices
Growth Drivers
The proliferation of connected medical devices and AI-powered diagnostics has dramatically increased the complexity of verification and validation requirements, creating outsized demand for specialized testing services. Stringent global regulatory frameworks enforced by agencies such as the FDA mandate comprehensive validation protocols before devices can be commercialized. Meanwhile, widespread inconsistencies across regional verification standards have driven medical device manufacturers to increasingly rely on outsourced testing and validation providers to navigate disparate compliance landscapes.
- •IoMT device proliferation, with some projections indicating millions of new connected devices entering healthcare environments, requiring rigorous security and safety validation
- •Cybersecurity testing for wearable medical devices reaching approximately $490 million in 2025, projected to grow at 11.8% CAGR through 2036
- •Inconsistencies across regional verification standards driving increased demand for outsourced validation services
Segmentation and Regional Analysis
The market spans multiple device categories, with point-of-care infectious disease diagnostics representing a particularly dynamic segment that reached $53.1 billion in 2024, each requiring tailored validation frameworks. Wearable medical device cybersecurity test systems constitute a rapidly growing sub-segment valued at approximately $490 million in 2025. Geographically, North America and Europe remain the largest markets due to stringent FDA and EU regulatory requirements, while Asia-Pacific is emerging as a significant growth region driven by expanding healthcare infrastructure and manufacturing activity.
- •Point-of-care diagnostics segment reached approximately $53.1 billion in 2024, requiring extensive regulatory and technical validation
- •Cybersecurity test systems for wearable devices valued at approximately $490 million in 2025
- •Regional fragmentation in verification standards creates both complexity and opportunity for global testing providers
Trends and Outlook
What are the recent trends and outlook?
Artificial intelligence and machine learning in medical devices are creating entirely new validation paradigms, as traditional verification frameworks must be adapted to accommodate models that evolve post-deployment. Synthetic human tissue models and digital twin technologies are emerging as cost-reduction strategies that could reshape testing methodologies and reduce time-to-market for new devices. The continued expansion of IoMT deployments, combined with heightened awareness of device security vulnerabilities, will likely drive sustained double-digit market growth through the decade.
- •AI and ML medical devices are creating new validation requirements as traditional frameworks adapt to self-learning algorithms
- •Synthetic tissue models and digital twins are being explored as cost-reduction strategies in device development and testing
- •Healthcare cybersecurity vulnerabilities in medical devices and software are accelerating demand for comprehensive verification services
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.